PHIO
Phio Pharmaceuticals Corp.
+0.01 (+1.10%)1.01USD17.4K成交股數11.7M市值–本益比(近四季)50.8股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 3.1M | 2.8M | 1.5M | 1.2M | 1.1M | 886K | 644K | 866K | 1.1M | 1.0M | 1.8M | 1.4M |
| 銷售管理費用 | 1.2M | 1.4M | 1.1M | 1.3M | 1.2M | 986K | 946K | 1.0M | 1.1M | 766K | 968K | 1.2M |
| 營業利益 | −4.3M+85% | −4.2M+123% | −2.5M+59% | −2.5M+31% | −2.3M+5% | −1.9M-1% | −1.6M-43% | −1.9M-25% | −2.2M | −1.9M | −2.8M | −2.5M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −4.1M+91% | −4.0M+126% | −2.4M+56% | −2.4M+30% | −2.2M+1% | −1.8M-7% | −1.5M-45% | −1.8M-28% | −2.2M | −1.9M | −2.8M | −2.5M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | – | – | – | – | -0.45-4% | -0.41-98% | -1.54-85% | -3.62-73% | -0.47 | -20.09 | -10.25 | -13.27 |
| 稀釋股數 | – | – | – | – | 4.8M | 4.3M | 990K | 510K | 4.6M | 232K | 271K | 192K |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 13.0M | 17.0M | 21.0M | 10.7M | 10.8M | 13.3M | 5.4M | 4.7M | 6.5M | 8.5M | 8.4M | 11.3M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 14.3M | 17.4M | 21.5M | 11.5M | 11.3M | 13.4M | 5.9M | 5.3M | 6.9M | 9.4M | 9.5M | 12.3M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 1.7M | 950K | 1.3M | 1.7M | 1.2M | 1.3M | – | – | – | 1.6M | 2.3M | 2.4M |
| 股東權益 | 12.6M | 16.5M | 20.1M | 9.8M | 10.1M | 12.2M | 4.9M | 3.8M | 5.6M | 7.7M | 7.2M | 9.9M |
| 負債比 | 11.9% | 5.5% | 6.2% | 14.5% | 10.7% | 9.4% | – | – | – | 17.4% | 24.4% | 19.5% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −4.0M+214% | – | – | – | −1.3M | – | – | −2.0M | – | – | – |
| 資本支出 | – | 0.00 | – | – | – | 2K | – | – | 0.00 | – | – | – |
| 自由現金流 | – | −4.0M+213% | – | – | – | −1.3M | – | – | −2.0M | – | – | – |
| 折舊攤銷 | – | 1K | – | – | – | 0.00 | – | – | 1K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −8.7M | –% | – | −8.0M |
| FY2024 | 231K | -2987.5% | −7.2M | -3,095.2% | -9.08 | −7.1M |
| FY2023 | −8K | – | −10.8M | 135,325.0% | -46.76 | −10.8M |
| FY2022 | – | – | −11.5M | –% | -10.10 | −12.3M |
| FY2021 | – | – | −13.3M | –% | -12.43 | −11.9M |
| FY2020 | 0.00 | -100.0% | −8.8M | –% | -1.92 | −8.8M |
| FY2019 | 21K | -84.8% | −8.9M | -42,419.0% | -19.33 | −8.7M |
| FY2018 | 138K | – | −7.4M | -5,333.3% | -57.46 | −7.5M |